Infection and primary Biliary cirrhosis

Israel Medical Association Journal

Volumn 11, Issue 2, 2009, Pages 112-115

  Agmon Levin, Nancy ^a   Katz, Bat Sheva Porat ^b   Shoenfeld, Yehuda ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Environmental factors; Infectious diseases; Molecular mimicry; Primary biliary cirrhosis

Indexed keywords

BILIARY CIRRHOSIS; CHLAMYDOPHILA INFECTION; ESCHERICHIA COLI INFECTION; HELICOBACTER INFECTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIOSIS; REVIEW; VIRUS INFECTION;

CHLAMYDOPHILA INFECTIONS; ESCHERICHIA COLI INFECTIONS; HELICOBACTER INFECTIONS; HUMANS; LIVER CIRRHOSIS, BILIARY; MYCOBACTERIUM INFECTIONS; VIRUS DISEASES;

EID: 66149085667     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273.
2. Jones D. Pathogenesis of primary biliary cirrhosis. Gut 2007; 56: 1615-1624.
3. Van de Water J, Gershwin ME, Leung P, et al. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988; 167: 1791-1799.
4. Gershwin ME, Selmi C, Worman H, et al. Risk factors and comorbidities in primary biliary cirrhosis: a control interview-based study of 1032 patients. Hepatology 2005; 42: 1194-1202.
5. Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007; 28(2-3): 76-84.
6. Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics and environment. Gastroenterology 2004; 127: 485-492.
7. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47: 737-745.
8. Ala A, Stanca CM, Bu-Ghanim M, et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006; 43: 525-531.
9. Barzilai O, Sherer Y, Ram M, et al. Epstein Barr virus and cytomegalovirus in autoimmune disease. Are they truly notorious? A preliminary report. Ann NY Acad Sci 2007; 1108: 567-577.
10. Tanka A, Prindiville T P, Gish R, et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999; 31: 664-671.
11. Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 2007; 19: 636-643.
12. He XS, Ansari AA, Ridgway WM, et al. New insights to the immunopathology of autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006; 239(1): 1-13.
13. Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991; 100: 822-833.
14. Metcalf J V, Mitchison HC, Palmar JM, Jones DE, Basssendine ME, James OF. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-1402.
15. Kita H, Matsumura S, He X, et al. Quantitative and functional analysis of PDC-E2 specifc autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002; 109: 1231-1240.
16. Jones DEJ, Palmar JM, Yeaman SJ, et al. T-cell response to the component of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995; 21: 995-1002.
17. Shimoda S, Nakamura M, Shigematsu H, et al. HLA-DRB4 0101-restricted immunosominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181: 1835-1845.
18. Kita H, Lian ZX, Van der Water J, et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell response in primary biliary cirrhosis: T cell activation is augmented by immune complex cross-presented by dendritic cells. J Exp Med 2002; 195: 113-123.
19. Jones DEJ, Robe AJ, Kirbi JA, et al. Adoptive transfer of self-PDC-reactive T-cells into naïve mice induces portal tract and bile duct changes characteristic of primary biliary cirrhosis (PBC). J Hepatol 2006; 44: S10.
20. Tanimoto H, Shimoda S, Nakamura M, et al. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J Autoimmun 2003; 20: 255-263.
21. Mao TK, Lian ZX, Selmi C, et al. Altered monocytes response to defined TLR ligands in a patient with primary biliary cirrhosis. Hepatology 2005; 42: 802-808.
22. Yokoyama T, Komori A, Nakamura M, et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NFkB and MAPK signaling pathways. Liver Int 2006; 26: 467-476.
23. Shoenfeld Y, Rose NR. Introduction: Infection and autoimmunity. In: Shoenfeld Y, Rose NR, eds. Infection and Autoimmunity. Amsterdam: Elsevier, 2004: 613-622.
24. Wucherpfenning KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001; 108: 1097-1104.
25. Lehmann P V, Forsthuber T, Miller A, et al. Spreading of T-cell autoimmunity for cryptic determinants of an autoantigen. Nature 1992; 358: 155-157.
26. Bogdanos D P, Baum H, Grasso A, et al. Microbial mimics are major targets of cross reactivity with human pyruvate dehydrogense in primary biliary cirrhosis. J Hepatol 2004; 40: 31-39.
27. Klein R, Wiebel M, Engelhart S, et al. Sera from patients with tuberculosis recognize the M2a-epitope (E2 subunit of pyruvate dehydrogenase complex) specific for primary biliary cirrhosis. Clin Exp Immunol 1993; 92: 308-316.
28. Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta 1995; 1271: 111-121.
29. Burroughs AK, Rosenstein IJ, Epstein O, et al. Bacteriuria and primary biliary cirrhosis. Gut 1984; 25: 133-137.
30. Hopf U, Moller B, Stemerowicz R, et al. Relation between Escherichia coli. R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989; ii: 1419-1422.
31. Butler P, Hamilton Miller JMT, Baum H, Burroughs AK. PBC specific M2 autoantibodies in patients with recurrent urinary tract infection using an ELISA and purified pyrovatedehydrogenase, Gut 1993; 34(Suppl 1): S30.
32. Miyakawa H, Tanaka A, Selmi C, et al. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Clin Dev Immunol 2006; 13: 289-294.
33. Shimoda S, Nakamura M, Shigematsu H, et al. Mimicry peptides of human PDC-E2 163-176 peptides, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000; 31: 1212-1216.
34. Selmi C, Balkwill DL, Invernizzi P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic metabolizing bacterium. Hepatology 2003; 38: 1250-1257.
35. Abdulkarim AS, Petrovic LM, Kim WR, et al. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumonia? J Hepatol 2004; 40: 380-384.
36. Taylor-Robinson D, Sharif AW, Dahanjal NS, Taylor-Robinson SD. Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis. J Hepatol 2005; 42: 778-780.
37. Durazzo M, Rosina F, Premoli A, et al. Lack of association between sero-prevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol 2004; 10: 3179-3181.
38. Boomkens SY, de Rave S, Pot RG, et al. The role of Helicobacter spp. In the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis. FEMS Immunol Med Microbiol 2005; 44: 221-225.
39. Vilagut L, Pares A, Vinas O, et al. Antibodies to mycobacterial 65 kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest 1997; 27: 667-672.
40. O'Donohue J, McFarlane B, Bomford A, et al. Mycobacteria in primary biliary cirrhosis. J Hepatol 1994; 21: 887-889.